Navigation Links
Susan G. Komen for the Cure(R) Advocacy Alliance Responds to President Barack Obama's Address to Congress
Date:2/24/2009

'Discovering and Delivering the Cures to Cancer Must Be a Top National Priority'

WASHINGTON, Feb. 24 /PRNewswire/ -- Martina Hone, president of the Susan G. Komen for the Cure(R) Advocacy Alliance, issued the following statement in response to President Barack Obama's address to a joint session of Congress this evening:

(Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO)

"This is a critical time in our nation's history. We are confronted with large health care challenges. Yet the potential to significantly improve access to critical health care services for all and to make meaningful progress in discovering the cures to cancer provide us with the hope of an exciting and healthier future.

"We were grateful Congress and the Administration took the first step in addressing the growing health care crisis in the states with the recent economic stimulus legislation. These funds give states the opportunity to avoid cuts to potentially life-saving breast cancer education, screening and treatment services for underserved women.

"Yet there is so much more to do. As the non-partisan voice for over 2.5 million breast cancer survivors and the people who love them, we look forward to working with President Obama to establish a health system that ensures access to affordable, high-quality health care for all - including underserved populations and people with chronic or pre-existing conditions like cancer.

"We must ensure that everyone has access to breast cancer screening and treatment. For breast cancer, as is the case for many diseases, early detection is the closest thing we have to prevention. Detecting cancer early not only increases a patient's chance of survival, but also considerably reduces the cost of their treatment.

"We were also thankful for the considerable investment in health research contained in the stimulus legislation. We urge the Administration to intensify this commitment to discovering the cures, as funding has remained essentially flat since 2003. We must signal that discovering and delivering the cures for cancer is a top national priority."

The Susan G. Komen for the Cure Advocacy Alliance is a voice for change on Capitol Hill, in state legislatures and on the campaign trail. With the help of nearly 200,000 Komen Champions and Komen's network of 122 domestic affiliates, we are aggressively seeking increased funding for research and greater access to screening and treatment. The Komen Advocacy Alliance engages policymakers and leaders at all levels of government to advocate for an increased investment in breast cancer research and greater access to breast health services.


'/>"/>
SOURCE Susan G. Komen for the Cure(R) Advocacy Alliance
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Susan G. Komen for the Cure(R) Advocacy Alliance Applauds Congress for Including Health Care Assistance; Research in Economic Stimulus
2. Dr Pepper Snapple Group Product Goes Pink in Support of Susan G. Komen for the Cure(R)
3. New Balance Celebrates the 20th Anniversary of Susan G. Komen for the Cure(R) Partnership
4. Virgin Mobile USA Launches Limited Edition Pink Flare Handset to Benefit Susan G. Komen for the Cure(R)
5. Susan Lark, MD Continues to Urge Women to Fight for Their Right to Use Bioidentical Hormones
6. Susan G. Komen for the Cure(R) and Triple Negative Breast Cancer Foundation Unite to Fight Aggressive Form of Breast Cancer
7. Susan Knapp Pinnas Named AvMed Health Plans New Senior Vice President of Network
8. Dr. Susan Lark's Squalane Now Made From Olives, Not Sharks
9. Susan Lark, MD Urges Women to Fight for Their Right to Use Bioidentical Hormones
10. Susan G. Komen for the Cure(R) Advocacy Alliance Applauds Selection of Senator Tom Daschle for HHS Secretary, White House Health Reform Czar
11. Susan G. Komen for the Cure(R) Announces Recipients of 2008 Komen Brinker Award for Scientific Distinction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin ... companies that call for a minimum wage raise to $12 an hour by 2020 and ... This will restore the lost value of the minimum wage, assure the wage floor does ...
(Date:6/24/2016)... ... 24, 2016 , ... EB Medicine presented its first-ever “Issue ... conference in Ponte Vedra Beach, FL. The awards honor the outstanding work of ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology: